Compare FMC Corp (FMC) vs Global X Uranium ETF (URA) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

URA (Global X Uranium ETF) trades at $39.67, down 4.52% in the last session amid a bearish technical setup with 17 sell signals versus 3 buy signals. The ETF faces pressure from moving averages but finds some support from oversold RSI levels. Recent news highlights uranium's strategic positioning for AI energy demand and nuclear power's resurgence, though the fund trails pure-miner alternatives that have outperformed with 61% gains.

The ETF's outlook is supported by structural demand from AI data centers and policy tailwinds, including $17.5 billion in U.S. government loans for nuclear projects. However, high expense ratios (0.52%) and competition from more focused uranium funds present risks. Technical weakness suggests near-term consolidation, but long-term nuclear adoption trends offer growth potential.